撞击综合征市场按类型、撞击部位、患者年龄层、治疗类型和地区划分

撞击症候群市场规模预计在 2025 年达到 15.8 亿美元，预计到 2032 年将达到 25.371 亿美元，2025 年至 2032 年的复合年增长率为 7%。

撞击症候群是指肩峰下间隙变窄，导致肩迴旋肌肌肉肌腱受到挤压的一种疾病。肩袖肌腱在经过上臂顶端（肱骨）和肩峰之间时会受到挤压。撞击症候群的治疗方法因撞击严重程度而异，从简单的家庭治疗（例如服用阿斯匹灵和休息）到手术治疗不等。撞击肩迴旋肌，也称为肩部撞击，是指肩迴旋肌肌肉肌腱受到挤压的疾病。当肌腱穿过肩部一个称为肩峰下间隙的狭​​窄骨性间隙时，就会发生这种情况。当这些肌腱受到挤压时，会引起疼痛和不适，尤其是在抬起手臂时。撞击症候群可能是由重复的手臂运动或过顶活动引起的，这些活动会导致肩迴旋肌肌腱肿胀和发炎。撞击症候群常见于涉及大量过顶动作的运动，例如网球、游泳和举重，以及需要重复手臂动作的工作。撞击症候群的症状包括持续性肩部疼痛、夜间疼痛加剧以及难以伸手到背后。您也可能在举起手臂或投球时感到疼痛。撞击症候群的治疗通常包括物理治疗、非类固醇消炎剂(NSAID) 和皮质类固醇注射。严重病例可能需要手术。

市场动态：

肌肉骨骼疾病盛行率上升、老年人口增长、对安全有效治疗的需求增加以及研发增加是预计推动全球撞击症候群市场成长的关键因素。

例如，根据世界卫生组织（WHO）的数据，到2022年7月，全球约有17.1亿人将患有肌肉骨骼疾病。肌肉骨骼疾病是全球残疾的主要原因，其中腰痛是160个国家残疾的主要原因。世卫组织推出「復健2030」倡议，以支持各国满足现有的復健需求，包括肌肉骨骼疾病患者的復健需求，以及预计健康和人口趋势将带来的成长。

本研究的主要特点

• 本报告对全球撞击综合症市场进行了详细分析，并给出了预测期（2025-2032）的市场规模和年复合成长率(CAGR)，假设 2024 年为基准年。
• 它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 该报告涵盖了全球撞击综合症市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、关键亮点、业绩和策略。
• 本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球撞击综合症市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员可以透过用于分析全球撞击症候群市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
• 患病率不断上升
• 提高认识和诊断
• 诊断技术的进步
  • 限制因素
• 治疗费用高
• 有限退费政策
• 治疗结果的差异
  • 机会
• 新的治疗方法
• 病患教育与自我管理
• 远端医疗和远端监控
• 主要亮点
• 监管情景
• 近期动态
• 产品发布/核准
• PEST分析
• 波特分析
• 合併、收购和合作

4. 全球撞击症候群市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年全球撞击症候群市场（按类型）

• 原发性撞击症候群
• 继发性撞击症候群

6. 全球撞击症候群市场（依撞击部位划分），2020 年至 2032 年

• 肩膀
• 肩峰下
• 冈上肌腱和冈下肌腱
• 喙突
• 肩胛上神经
• 肩胛下肌腱
• 二头肌肌腱
• 其他（肩迴旋肌症候群、肩肱关节撞击等）

7. 2020 年至 2032 年按患者年龄族群分類的全球撞击症候群市场

• 儿科（儿童和青少年）
• 成人（18-65岁）
• 老年人（65岁或以上）

8. 2020 年至 2032 年全球撞击症候群市场（依治疗类型）

• 药品
• 物理治疗
• 可的松注射
• 外科手术
• 替代治疗
• 其他（矫正器具、辅助器具）

9. 2020 年至 2032 年按地区分類的全球撞击症候群市场

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 以色列
  • 北非
  • 中部非洲
  • 其他中东和非洲地区

第十章 竞争格局

• 公司简介
  • Johnson &Johnson（DePuy Synthes）
  • Medtronic plc
  • Breg, Inc.
  • CONMED Corporation
  • Ossur hf.
  • Colfax
  • Globus Medical, Inc.
  • Wright Medical Group NV
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Bioventus LLC

第 11 章 章节

• 参考
• 调查方法
• 关于出版商

Impingement Syndrome Market is estimated to be valued at USD 1,580.0 Mn in 2025 and is expected to reach USD 2,537.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7% from 2025 to 2032.

Impingement syndrome refers to the narrowing of the subacromial space which leading to impingement of the tendons of the rotator cuff muscles. It is a condition in which the tendons of the rotator cuff of the shoulder are pinched as they pass between the top of the upper arm (humerus) and the tip of the shoulder (acromion). Impingement syndrome treatment can range from simple home treatment such as aspirin and rest to surgery, depending on how severe the impingement is. Impingement syndrome, also known as shoulder impingement, is a condition where the tendons of the rotator cuff muscles become compressed. This happens when these tendons pass through a narrow bony space in the shoulder called the subacromial space. The pressure on these tendons can cause pain and discomfort, especially when lifting the arm. Impingement syndrome can be caused by repetitive arm movements or overhead activities, which can lead to swelling and inflammation of the rotator cuff tendons. This is common in sports that require a lot of overhead movements like tennis, swimming, or weightlifting, and jobs that require repetitive arm movements. Symptoms of impingement syndrome include persistent pain in the shoulder, pain that worsens at night, and difficulty reaching up behind the back. Pain may also occur when lifting the arm overhead or while throwing a ball. Treatment for impingement syndrome often involves physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroid injections. In severe cases, surgery may be required.

Market Dynamics:

Increasing prevalence of musculoskeletal disorders, growing geriatric population, and rise in demand for safe & effective treatment, and increasing research and development are major factors expected to drive the growth of the global impingement syndrome market.

For instance, according to the World Health Organization (WHO), in July 2022, around 1.71 billion people across the globe worldwide have musculoskeletal conditions. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the leading cause of disability in 160 countries. WHO has launched Rehabilitation 2030 Initiative to support countries to respond to existing rehabilitation needs, including people with musculoskeletal conditions, as well as the forecasted increase arising from health and demographic trends.

Key features of the study:

• This report provides in-depth analysis of the global impingement syndrome market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global impingement syndrome market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Johnson & Johnson (DePuy Synthes), Medtronic plc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., Colfax, Ossur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., and Bioventus LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global impingement syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global impingement syndrome market

Detailed Segmentation:

• By Type:
  • Primary Impingement Syndrome
  • Secondary Impingement Syndrome
• By Impingement Site:
  • Shoulder
  • Subacromial
  • Supraspinatus and Infraspinatus Tendon
  • Coracoid
  • Suprascapular Nerve
  • Subscapularis Tendon
  • Biceps Tendon
  • Others (Rotator cuff tendinitis, Glenohumeral joint impingement, etc.)
• By Patient Age Group:
  • Pediatric (children and adolescents)
  • Adult (18-65 years)
  • Geriatric (65+ years)
• By Treatment Type:
  • Medication
  • Physical Therapy
  • Cortisone Injections
  • Surgery
  • Alternative Treatment
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • Johnson & Johnson (DePuy Synthes)
  • Medtronic plc.
  • Breg, Inc.
  • CONMED Corporation
  • Ossur hf.
  • DJO Global, Inc.
  • Globus Medical, Inc.
  • Wright Medical Group N.V.
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Bioventus LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Impingement Site
  • Market Snippet, By Patient Age Group
  • Market Snippet, By Treatment Type
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence
• Rising awareness and diagnosis
• Advancements in diagnostic technologies
  • Restraints
• High cost of treatment
• Limited reimbursement policies
• Variability in treatment outcomes
  • Opportunities
• New treatment modalities
• Patient education and self-management
• Telemedicine and remote monitoring
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Impingement Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Impingement Syndrome Market, By Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Primary Impingement Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Secondary Impingement Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Impingement Syndrome Market, By Impingement Site, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Shoulder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Subacromial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Supraspinatus and Infraspinatus Tendon
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Coracoid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Suprascapular Nerve
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Subscapularis Tendon
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Biceps Tendon
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others (Rotator cuff tendinitis, Glenohumeral joint impingement, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Impingement Syndrome Market, By Patient Age Group, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric (children and adolescents)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Adult (18-65 years)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Geriatric (65+ years)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Impingement Syndrome Market, By Treatment Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Physical Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cortisone Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Alternative Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others (Braces, Assistive devices)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Impingement Syndrome Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC
    • Israel
    • North Africa
    • Central Africa
    • Rest of Middle East & Africa

10. Competitive Landscape

• Company Profile
  • Johnson & Johnson (DePuy Synthes)
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Medtronic plc
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Breg, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • CONMED Corporation
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Ossur hf.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Colfax
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Globus Medical, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Wright Medical Group N.V.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Arthrex, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Orthofix Medical Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Bioventus LLC
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Analyst Views

11. Section

• References
• Research Methodology
• About us